Faisal M Merchant, MD

Emory Clinic

Assistant Professor of Medicine

Emory Healthcare Network Physician
Cardiac Electrophysiology (Board certified since 2014)
Cardiology (Board certified since 2009)
Internal Medicine (Board certified since 2006)
Areas of Clinical Interest:
arrhythmia ablation
atrial fibrillation ablation
implantable defibrillator
Office(s) Locations:
Emory Heart & Vascular Center at Midtown
550 Peachtree St NE
Atlanta, GA 30308
404 686-2504
Hospital Affiliation(s):
Emory University Hospital Midtown
Year Started Practicing: 2006
Year Started Practicing at Emory: 2009
Organizational Memberships:
American College of Cardiology
American Heart Association
Heart Rhythm Society
Alpha Omega Alpha
Major or Recent Publications:

Merchant FM, Noseworthy PA, Weiner RB, Singh SM, Ruskin JN, Reddy VY. Ability of terminal QRS notching to distinguish benign from malignant electrocardiographic forms of early repolarization. Am J Cardiol. 2009 Nov 15;104(10):1402-6.

Merchant FM, Heist EK, Nandigam KV, Mulligan LJ, Blendea D, Riedl L, McCarty D, Orencole M, Picard MH, Ruskin JN, Singh JP. Interlead distance and left ventricular lead electrical delay predict reverse remodeling during cardiac resynchronization therapy. Pacing Clin Electrophysiol. 2010 May:33(5):575-82.

Katritsis D*, Merchant FM*, Mela T, Singh JP, Heist EK, Armoundas AA.  Catheter ablation of atrial fibrillation: the search for substrate-driven end points.  J Am Coll Cardiol. 2010 May 25;55(21):2293-8.      

Merchant FM, Heist EK, McCarty D, Kumar P, Das S, Blendea D, Ellinor PT, Mela T, Picard MH, Ruskin JN, Singh, JP.  Impact of segmental left ventricle lead position on cardiac resynchronization therapy outcomes.  Heart Rhythm 2010 May;7(5):639-44.

Merchant FM, Dec GW, Singh JP.  Implantable sensors for heart failure.  Circ Arrhythm Electrophysiol. 2010 Dec 1;3(6):657-67.

Merchant FM, Ikeda T, Pedretti RF, Salerno-Uriarte JA, Chow T, Chan PS, Bartone C, Hohnloser SH, Cohen RJ, Armoundas AA.  Clinical utility of microvolt T-wave alternans testing in identifying patients at high or low risk of sudden cardiac death.  Heart Rhythm 2012 Aug;9(8):1256-64.

Merchant FM, Armoundas AA.  Role of substrate and triggers in the genesis of cardiac alternans, from the myocyte to the whole heart: implications for therapy.  Circulation 2012 Jan 24;125(3):539-49.

Armoundas AA, Weiss EH, Sayadi O, Laferriere S, Sajja N, Mela T, Singh JP, Barrett CD, Kevin Heist E, Merchant FM.  A novel pacing method to suppress repolarization alternans in vivo: implications for arrhythmia prevention.  Heart Rhythm 2013 Apr;10(4):564-72.

Merchant FM, Sayadi O, Moazzami K, Puppala D, Armoundas AA.  T-wave alternans as an arrhythmic risk    stratifier: state of the art.  Curr Cardiol Rep. 2013 Sept;15(9):398.

Merchant FM, Zheng H, Bigger T, Steinman R, Ikeda T, Pedretti RF, Salerno-Uriarte JA, Klersy C, Chan PS, Bartone C, Hohnloser SH, Ruskin JN, Armoundas AA.  A combined anatomic and electrophysiologic substrate based approach for sudden cardiac death risk stratification.  Am Heart J. 2013 Oct;166(4):744-52.

Merchant FM, Kella D, Book WM, Langberg JJ, Lloyd MS.  Cardiac resynchronization therapy in adult patients with repaired Tetralogy of Fallot and left ventricular systolic dysfunction.  Pacing Clin Electrophysiol. 2014 Mar;37(3):321-8.    

Merchant FM and De Lurgio DB.  Catheter ablation of atrial fibrillation and risk of asymptomatic cerebral embolism.  Pacing Clin Electrophysiol.  2014 Mar;37(3):389-97.

Finalist, Laennec Young Clinician Award 2007
American Heart Association

Young Clinician Investigator Award 2008
Johnson & Johnson®-CIMIT (Center for Integration of Medicine & Innovative Technology), Harvard University & Massachusetts Institute of Technology

ALTITUDE for Fellows Research Program 2012
Boston Scientific®
Medical School
Duke University School of Medicine, Durham, NC

Massachusetts General Hospital, Boston, MA

Massachusetts General Hospital, Boston, MA
Massachusetts General Hospital, Boston, MA
Emory University Hospital, Atlanta, GA